IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v59y2002i1p65-94.html

A review of the literature on the economics of noncompliance. Room for methodological improvement

Author

Listed:
  • Cleemput, Irina
  • Kesteloot, Katrien
  • DeGeest, Sabina

Abstract

No abstract is available for this item.

Suggested Citation

  • Cleemput, Irina & Kesteloot, Katrien & DeGeest, Sabina, 2002. "A review of the literature on the economics of noncompliance. Room for methodological improvement," Health Policy, Elsevier, vol. 59(1), pages 65-94, January.
    • Handle: RePEc:eee:hepoli:v:59:y:2002:i:1:p:65-94
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(01)00178-6
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. John A. Rizzo & Thomas A. Abbott & Steven Pashko, 1996. "Labour productivity effects of prescribed medicines for chronically ill workers," Health Economics, John Wiley & Sons, Ltd., vol. 5(3), pages 249-265, May.
    2. Baltussen, Rob & Ament, Andre & Leidl, Reiner, 1996. "Making cost assessments based on RCTs more useful to decision-makers," Health Policy, Elsevier, vol. 37(3), pages 163-183, September.
    3. Martin J. Buxton & Michael F. Drummond & Ben A. Van Hout & Richard L. Prince & Trevor A. Sheldon & Thomas Szucs & Muriel Vray, 1997. "Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 217-227, May.
    4. Helitzer-Allen, Deborah L. & McFarland, Deborah A. & Wirima, Jack J. & Macheso, Allen P., 1993. "Malaria chemoprophylaxis compliance in pregnant women: A cost-effectiveness analysis of alternative interventions," Social Science & Medicine, Elsevier, vol. 36(4), pages 403-407, February.
    5. Windsor, R.A. & Bailey, W.C. & Richards Jr., J.M. & Manzella, B. & Soong, S.-J. & Brooks, M., 1990. "Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma," American Journal of Public Health, American Public Health Association, vol. 80(12), pages 1519-1521.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Theodore Darkow & Henry Henk & Simu Thomas & Weiwei Feng & Jean-Francois Baladi & George Goldberg & Alan Hatfield & Jorge Cortes, 2007. "Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs," PharmacoEconomics, Springer, vol. 25(6), pages 481-496, June.
    2. Ananth Kadambi & Robert Leipold & Anuraag Kansal & Sonja Sorensen & Denis Getsios, 2012. "Inclusion of Compliance and Persistence in Economic Models," Applied Health Economics and Health Policy, Springer, vol. 10(6), pages 365-379, November.
    3. Hiligsmann, Mickaël & Rabenda, Véronique & Bruyère, Olivier & Reginster, Jean-Yves, 2010. "The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients," Health Policy, Elsevier, vol. 96(2), pages 170-177, July.
    4. van Esch, Thamar E.M. & Brabers, Anne E.M. & van Dijk, Christel E. & Gusdorf, Lisette & Groenewegen, Peter P. & de Jong, Judith D., 2017. "Increased cost sharing and changes in noncompliance with specialty referrals in The Netherlands," Health Policy, Elsevier, vol. 121(2), pages 180-188.
    5. Ana Teixeira & Maribel Teixeira & Maria Teresa Herdeiro & Viviana Vasconcelos & Rita Correia & Maria Fernanda Bahia & Isabel F. Almeida & Diogo Guedes Vidal & Hélder Fernando Pedrosa e Sousa & Maria A, 2021. "Knowledge and Practices of Community Pharmacists in Topical Dermatological Treatments," IJERPH, MDPI, vol. 18(6), pages 1-13, March.
    6. Karine Lamiraud & Pierre-Yves Geoffard, 2007. "Therapeutic non-adherence: a rational behavior revealing patient preferences?," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1185-1204.
    7. Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2015. "Behavioral Hazard in Health Insurance," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(4), pages 1623-1667.
    8. Abualbishr Alshreef & Nicholas Latimer & Paul Tappenden & Ruth Wong & Dyfrig Hughes & James Fotheringham & Simon Dixon, 2019. "Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Method," Medical Decision Making, , vol. 39(8), pages 910-925, November.
    9. Karine Lamiraud & Pierre‐Yves Geoffard, 2007. "Therapeutic non‐adherence: a rational behavior revealing patient preferences?," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1185-1204, November.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Tavares, Aida Isabel, 2025. "How does OTC drugs consumption relate to prescribed drugs and health care consultations in Europe?," Health Policy, Elsevier, vol. 155(C).
    2. Joseph F. Levy & Marjorie A. Rosenberg, 2019. "A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis," Medical Decision Making, , vol. 39(5), pages 593-604, July.
    3. Hossein Haji Ali Afzali & Laura Bojke & Jonathan Karnon, 2018. "Model Structuring for Economic Evaluations of New Health Technologies," PharmacoEconomics, Springer, vol. 36(11), pages 1309-1319, November.
    4. Warburton, Rebecca Nunn, 2005. "Patient safety -- how much is enough?," Health Policy, Elsevier, vol. 71(2), pages 223-232, February.
    5. Dixon, Padraig & Harrison, Sean & Hollingworth, William & Davies, Neil M. & Davey Smith, George, 2022. "Estimating the causal effect of liability to disease on healthcare costs using Mendelian Randomization," Economics & Human Biology, Elsevier, vol. 46(C).
    6. Hossein Haji Ali Afzali & Jonathan Karnon & Jodi Gray, 2012. "A proposed model for economic evaluations of major depressive disorder," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(4), pages 501-510, August.
    7. Berndt, Ernst R. & Finkelstein, Stan N. & Greenberg, Paul E. & Howland, Robert H. & Keith, Alison & Rush, A. John & Russell, James & Keller, Martin B., 1998. "Workplace performance effects from chronic depression and its treatment," Journal of Health Economics, Elsevier, vol. 17(5), pages 511-535, October.
    8. Yingying Zhang & Noemi Kreif & Vijay S. GC & Andrea Manca, 2024. "Machine Learning Methods to Estimate Individualized Treatment Effects for Use in Health Technology Assessment," Medical Decision Making, , vol. 44(7), pages 756-769, October.
    9. Grieve, Richard & Hutton, John & Green, Colin, 2003. "Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular field," Health Policy, Elsevier, vol. 64(3), pages 311-324, June.
    10. Cookson, Richard & Hutton, John, 2003. "Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective," Health Policy, Elsevier, vol. 63(2), pages 167-178, February.
    11. Huajie Jin & Paul Tappenden & Stewart Robinson & Evanthia Achilla & David Aceituno & Sarah Byford, 2020. "Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-18, July.
    12. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.
    13. Benatus Sambili & Ronald Kimambo & Yun Peng & Elison Ishunga & Edna Matasha & Godfrey Matumu & Rita Noronha & David P. Ngilangwa, 2016. "Factors Influencing Anti-Malarial Prophylaxis and Iron Supplementation Non-Compliance among Pregnant Women in Simiyu Region, Tanzania," IJERPH, MDPI, vol. 13(7), pages 1-12, June.
    14. Dominick Esposito & Eric Schone & Thomas Williams & Su Liu & Karen CyBulski & Rita Stapulonis & Nancy Clusen, "undated". "Prevalence of Unclaimed Prescriptions at Military Pharmacies," Mathematica Policy Research Reports 4babb5da8dd74adba68b04a4d, Mathematica Policy Research.
    15. Joan Gil & Antoni Sicras-Mainar & Eugenio Zucchelli, 2018. "Uncontrolled diabetes and health care utilisation: panel data evidence from Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 785-795, July.
    16. Yaling Yang & Lucy Abel & James Buchanan & Thomas Fanshawe & Bethany Shinkins, 2019. "Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK," PharmacoEconomics - Open, Springer, vol. 3(3), pages 281-291, September.
    17. Tlou Maggie Masenya & Francis Ssekitto & Sarah Kaddu & Sam Simati, 2024. "Management of Electronic Health Records in Virtual Health Environments: The Case of Rocket Health in Uganda," International Journal of Healthcare Information Systems and Informatics (IJHISI), IGI Global Scientific Publishing, vol. 19(1), pages 1-17, January.
    18. Peaucelle, Irina, 2002. "Capital social et anthroponomie," CEPREMAP Working Papers (Couverture Orange) 0204, CEPREMAP.
    19. Peaucelle, Irina, 2001. "Economie et santé : où en est la Russie ?," CEPREMAP Working Papers (Couverture Orange) 0105, CEPREMAP.
    20. repec:plo:pone00:0057777 is not listed on IDEAS
    21. An Tran-Duy & Annelies Boonen & Wietske Kievit & Piet Riel & Mart Laar & Johan Severens, 2014. "Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 32(10), pages 1015-1028, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:59:y:2002:i:1:p:65-94. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.